Dr Schiender

Over the past twenty years, Dr Schneider has directed $20 million in research grants from the National Institutes of Health and has conducted randomised controlled trials in hypertension and heart disease. He has published over 100 articles in journals and proceedings such as Hypertension, Journal of Clinical Hypertension, Circulation, American Journal of Hypertension, Journal of Clinical Psychology, International Journal of Psychophysiology, Behavioral Medicine and Journal of Aging and Health.

Dr Schneider has been a consultant to numerous US government agencies, including the National Institutes of Health (NIH), the Centers for Disease Control and Prevention, the Presidential Commission on Complementary and Alternative Medicine, and the U.S. Congress‚ Prevention Coalition. Dr Schneider is a frequent lecturer on natural health care at medical meetings on four continents.

Currently Dr Schneider is the director of the NIH-funded Institute for Natural Medicine and Prevention and professor of physiology and health at Maharishi University of Management, Fairfield, IA, USA.

Curriculum Vitae - Dr. R. H. Schneider

Curriculum Vitae

Robert H. Schneider, MD, FACC

Education

B.A., Antioch College
Majors in Chemistry-Biology and Psychology
Yellow Springs, Ohio, 1977

M.D., University of Medicine and Dentistry of New Jersey
New Jersey Medical School
Newark, NJ, 1981

Postgraduate Training

Resident in Internal Medicine
Department of Internal Medicine
University of Michigan Medical Center
Ann Arbor, Michigan, 1981‑1982

Fellow in Hypertension
Department of Internal Medicine
Division of Hypertension           
University of Michigan Medical School
Ann Arbor, Michigan, 1982‑1984

Board Certification

Diplomate, American Board of Preventive Medicine
Public Health and General Preventive Medicine
1998‑2008

Certified Specialist in Clinical Hypertension
American Society on Hypertension
1999‑present

Fellowships and Honors

Fellow of the American College of Cardiology (FACC), 2005 – present

Fellow of the Academy of Behavioral Medicine Research (FABMR), 1997 - present

Fellow, American Heart Association
Twenty‑First U.S. Seminar on Epidemiology and Prevention of
Cardiovascular Diseases, Tahoe City, California, 199

Medical Licensure

State of Iowa:  1984 - present

Professional Experience

2010 – Present:  Medical Director, Maharishi University of Management
Maharishi Ayurveda Health Center, Fairfield, Iowa

2008 – Present:  Dean, Maharishi College of Perfect Health, Maharishi University of Management, Fairfield, Iowa

2005 – Present:  Director and Senior Investigator, Center for Natural Medicine and Prevention, Maharishi University of Management Research Institute, Maharishi Vedic City, Iowa

2004 – Present:  Professor of Physiology and Health
Maharishi University of Management, Fairfield, Iowa

1999 – Present:  Director, Institute for Natural Medicine and Prevention
Maharishi University of Management, Fairfield, Iowa

1996 ‑ Present:  Co‑Director Doctoral Program in Physiology
Department of Physiological and Biological Sciences
Maharishi University of Management, Fairfield, Iowa

1995 ‑ Present:  Professor of Physiology and Health
Department of Physiological and Biological Sciences
Maharishi University of Management, Fairfield, Iowa

1996 ‑ 2004:  Dean, College of Maharishi Consciousness Based Health Care
Maharishi University of Management, Fairfield, Iowa

1996 ‑ 1997:  Medical Director, Maharishi Medical Center
The Mansion, Maharishi Vedic City, Iowa

1993 ‑ 1995:  Visiting Associate Professor of Medicine and Psychiatry
Departments of Internal Medicine and Psychiatry
Rush Medical College, Chicago, Ill.

1989 ‑ 1995:   Associate Professor of Physiology
Department of Physiological and Biological Sciences
Maharishi University of Management, Fairfield, Iowa

1986 ‑ 1999:   Director, Center for Health and Aging Studies
Maharishi University of Management, Fairfield, Iowa

1985 ‑ 1995:  Associate Director, Institute of Maharishi Ayur‑Veda
Maharishi University of Management, Fairfield, Iowa

1985 ‑ 2004:  Medical Co-Director
College Medical Associates
Maharishi University of Management, Fairfield, Iowa

1984 ‑ 1989:  Assistant Professor of Physiology
Department of Physiological and Biological Sciences
Maharishi International University, Fairfield, Iowa

Grant Support

1.   Co-Investigator:  A Randomized Controlled Trial of Meditation Compared to Exposure Therapy and Education Control on PTSD in Veterans  (in collaboration with VA Medical Center, San Diego, CA) Department of Defense - U.S. Army Medical Research and Materiel Command, $2,434,501, 2012-2016

2.   Principal Investigator:  Randomized Controlled Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in African Americans, National Institutes of Health – National Heart, Lung and Blood Institutes, $998,500, 2009-2013.

3.   Principal Investigator:  Mechanisms of Meditation in Hypertension in Blacks, National Institutes of Health – National Heart, Lung and Blood Institutes, $2,428,674, 2007-2012.

4.  Principal Investigator:  Stress Reduction and Cardiovascular Morbidity and Mortality in Blacks – II (competitive renewal), National Institutes of Health – National Heart, Lung and Blood Institute, $1,939,000, 2003-2009.

5.   Principal Investigator:  The Effects of Consciousness Based Education on Neurophysiology, Cognitive Development and Health in College Students, Abramson Family Foundation and private donors, $950,000, 2005-2007.

6.  Principal Investigator: Center for Natural Medicine and Prevention, National Institutes of Health – National Center for Complementary and Alternative Medicine, $7,925,000, 1999-2005.

7. Principal Investigator: Stress Reduction and Atherosclerotic Heart Disease in Blacks, National Institutes of Health – National Heart, Lung and Blood Institutes, $1,763,000, 1999-2006.

8.  Principal Investigator: Stress Reduction in the Treatment of Advanced Breast Cancer in Elderly Women: Enhancing Survival and Quality of Life, Retirement Research Foundation, $475,000, 1999-2002.

9.  Co-Principal Investigator: Effects of Meditation on Mechanisms of CHD, National Institutes of Health – Office of Alternative Medicine, in collaboration with Cedars Sinai Medical Center, $1,100,000, 1999-2002.

10. Principal Investigator: Stress Reduction and Prevention of Hypertension in Blacks, National Institutes of Health – National Heart, Lung and Blood Institute, $2,260,000, 1998-2003.

11. Co-Investigator: Stress Reduction and Myocardial Ischemia in Blacks, Academic Research Enhancement Award – National Heart, Lung and Blood Institute, $95,000, 1998-2001.

12. Principal Investigator: Stress Reduction and Cardiovascular Disease Mortality and Morbidity in African Americans, National Institutes of Health – National Heart, Lung and Blood Institute, $1,600,000, 1997-2001.

13. Principal Investigator: Minority Researcher Supplement Award – Post Doctoral Fellowship, National Institutes of Health – National Heart, Lung and Blood Institute, $128,000, 1996-1998.

14. Sponsor:  National Research Service Award Senior Fellowship, National Institutes of Health – National Institute on Aging and Office of Alternative Medicine, $110,000, 1995-1998.

15. Principal Investigator: Minority Researcher Supplement Award – Graduate Assistantship, National Institutes of Health – National Heart, Lung and Blood Institute, $120,000, 1995-1998.

16. Principal Investigator:  Minority Researcher Supplement Award – Post Doctoral Fellowship, National Institutes of Health – National Heart, Lung and Blood Institute, $250,000, 1995-1998.

17. Principal Investigator:  Antihypertensive and Lipid-Lowering Treatment to Prevent Hearth Attack Trial (ALLHAT), Family Practice Center, Ottumwa, Iowa, 1994-2001.

18. Principal Investigator:  Supplement to Health Promotion and Disease Prevention in the Elderly – A Randomized Controlled Trial of Modern and Traditional Approaches, Retirement Research Foundation, $45,000, 1994-1997.

19. Principal Investigator:  Health Promotion and Disease Prevention in the Elderly – A Randomized Controlled Trial of Modern and Traditional Approaches, Retirement Research Foundation, $450,000, 1994-1997.

20. Principal Investigator:  Stress Reduction and Hypertensive Heart Disease in Blacks, National Institutes of Health – National Heart, Lung and Blood Institute, $920,000, 1994-1998.

21. Principal Investigator: Minority Researcher Supplement Award – Graduate Assistantship, National Institutes of Health – National Heart, Lung and Blood Institute, $120,000, 1992-1996.

22. Principal Investigator: Minority Research Supplement Award – Post Doctoral Fellowship, National Institutes of Health, National Heart, Lung and Blood Institute, $280,000, 1992-1996.

23. Principal Investigator: Stress Reduction in Elderly African Americans with Hypertension, National Institutes of Health – National Heart, Lung and Blood Institute, $980,000, 1992-1996.

24. Principal Investigator:  Modifying Cardiovascular Reactivity in the Laboratory and Field, National Institutes of Health – National Heart, Lung and Blood Institute, $130,000, 1989-1992.

25. Consultant: Stress Reduction in African American College Students, National Institutes of Health – Minority Biomedical Research Support Program, Carolyn Gaylord, Ph.D., Principal Investigator, University of Arkansas, Pine Bluff, Ark., 1989-1992.

26. Principal Investigator: Stress Reduction for the Treatment of Hypertension, Promotion of Mental Health, and Prevention of Cardiovascular Disease in an Elderly Black Population, Retirement Research Foundation, $235,000, 1989-1991.

27. Co-Principal Investigator:  A Randomized, Double Blind, Placebo-Controlled Trial of Metoprolol for the Treatment of Type A Behavior, Stevo Julius, M.D., Principal Investigator, Ciba-Geigy Corporation, $50,000, 1982-1984.

28. Consultant:  Stress and Anger Management for Blacks with Hypertension, National Institutes of Health – National Heart, Lung and Blood Institute, 1998-1999.

29. Consultant: Managing Multiple Risk Factors for Cardiovascular Disease, U.S. Department of Defense, 1998-2000.

Editorial Positions

Editorial Board, Clinical Trials and Meta‑Analysis, 1993‑1995               

Advisory Board, Alternative Therapies in Health and Medicine, 1994‑1997

Associate Editor, Controlled Clinical Trials, 1994‑1996

Editor, Frontiers in Bioscience, special issue on Frontiers in Natural Medicine Research, 2000-present

Co-editor, Journal of Social Behavior and Personality, special issue on Maharishi Vedic Psychology, dedicated to the work of Charles N. Alexander, Select Press, 2006

Editorial Board, World Journal of Cardiology, 2011

Review Committees

Retirement Research Foundation, Chicago, Ill. 1991

NIH — National Institute on Aging, 1992

NIH — Office of Alternative Medicine, 1993, 1995

NIH — National Institute on Child and Human Development, 1998

NIH — Office of Behavioral and Social Science Research, 1998

NIH — National Center for Complementary and Alternative Medicine, 2006

Expert Panels (invited)

1.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. Stress Prevention:  Its Impact on Health and Medical Savings. Panel presentation to the U.S. Congress, Prevention Coalition, Washington, D.C., June 24, 1998.

2.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. Achieving Parity in Health Care for Minority Populations:  Prevention of Hypertension and Heart Disease.  Presentation with Surgeon General Satcher to the U.S. Congress, Prevention Coalition, Washington, D.C., June 3, 1999.

3.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. Stress Reduction in the Prevention and Treatment of Cardiovascular Disease in High-risk Minority Populations. Presentation to the Congressional Prevention Coalition: Achieving Parity in Health Care for Minority Populations: Prevention of Hypertension and Heart Disease, Washington, D.C., June 3, 1999.

4.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H.  Current Research on Stress Reduction and Cardiovascular Disease in Minorities.  Presentation to the Expert ConsultantÕs Workgroup on Stress and Preterm Delivery, Centers for Disease Control and Prevention, Atlanta, Ga., Sept. 23‑24, 1999.

5.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H.  Research in Maharishi Vedic Medicine for Prevention and Treatment of Chronic Diseases. Invited presentation to the select members of the House of Lords, British Parliament, London, England, March 3, 2000.

6.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. The significance of the Maharishi Vedic Approach to Health for Modern Health Care and Medical Education.  O. C. Tanner Symposium on Body, Mind, and Spirit:  Culture and Health in America, Utah State University, Logan, Utah, April 14, 2000.

7.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. The role of Maharishi Vedic Medicine in the Prevention and Treatment of Cardiovascular and Other Chronic Diseases in Contemporary Society.  Luce Faculty Seminar on Science, Alternative Medicine and the Law.  Program in Brain, Mind and Medicine – Cross-Cultural Perspectives, Pitzer, Claremont McKenna and Harvey Mudd Colleges, Claremont, Calif., April 9, 2001.

8.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. The role of Vedic Medicine in Contemporary American Health Policy.  Invited presentation to the White House Commission on Complementary and Alternative Medicine Policy, Washington, D.C., Dec. 4, 2000.

9.     {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. The Maharishi Vedic Approach to Health. Presentation, panel and workshop at Complementary Medicine and Spirituality: Belief Systems, Culture and Health, Institute of Spirituality and Medicine, The John Hopkins University School of Medicine, Towson, Md., May 13-15, 2002.

10.  {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R.H. The Prevention and Treatment of Cardiovascular Disease in a Traditional System of Natural Medicine: Controlled Clinical Research on Maharishi Vedic Medicine.  Presentation to the National Institutes of Health – National Center for Complementary and Alternative Medicine, Bethesda, Md., May 16, 2002.

11.  {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R. H. A Review of Research on Maharishi Vedic Medicine: Diagnostic, Preventive, and Treatment Strategies. Presentation to the Indo-U.S. Science and Technology Forum, Delhi, India, October 21, 2003.

Professional Memberships (past and present)

American Psychosomatic Society

Society for Behavioral Medicine

International Society on Hypertension in Blacks

American College of Cardiology

American Heart Association:  Council on Epidemiology and Prevention

American College of Preventive Medicine

American Society of Hypertension

Academy of Behavioral Medicine Research

Media Coverage

Dr. Schneider and colleaguesÕ research has been featured in more than 1,000 magazine and newspaper articles, including: New Scientist, American Health, Self, LetÕs Live, Insight, Health, Longevity, American Medical News, Medical Tribune, The New York Times, Wall Street Journal, Washington Post, Los Angeles Times, Chicago Tribune, Boston Globe, San Francisco Chronicle, BBC News, London Daily Telegraph, Paris Match, Jerusalem Post, Indian Express, Times of India, Tehran Times, Ethiopian Review, Cambodian Times, the Associated Press, Reuters, and French News Agency.                           His work has also been featured on numerous television and radio news broadcasts, including ABCÕs 20/20, NBCÕs Dateline, CNN Headline News, CNN Health Special, ABC National Radio Network, UPI National Radio Voice of America, and Health Watch (for all English‑speaking nations).

Books

Schmidt-Wilk, J., Orme-Johnson, D. Alexander, V., Schneider, R.H. Applications of Maharishi Vedic Science – Honoring the Lifework of Charles N. Alexander, Ph.D. Select Press, 2005.

Schneider R.H., Fields J.Z. Total Heart Health: How to Prevent and Reverse Heart Disease with the Maharishi Vedic Approach to Health. Laguna Beach, CA, Basic Health Publications, 2006.

Dillbeck M.C., Barnes V., Schneider R.H., Travis F., and Walton, K. (eds.). Scientific research on Maharishi's Transcendental Meditation and TM-Sidhi Programme: Collected papers, volume 7. Vlodrop, The Netherlands: Maharishi Vedic University Press. (in press).

Publications – Peer Reviewed

1.     Creese I., Schneider R.H., Snyder H.  3H‑Spiroperidol Labels Dopamine Receptors in Pituitary and Brain.  European Journal of Pharmacology, 46:377, 1977.

2.     Julius S., Fitzpatrick M.A., Egan B., Schneider R.H. Neural Mechanisms in Clinical Hypertension. In Guthrie Jr. G.P., Kotche T.A. (Eds.):  Hypertension and the Brain.  New York: Futura Publications, Ch. 14, pp. 305‑318, 1984.

3.     Egan B., Fitzpatrick M.A., Schneider R.H., Julius S. Vascular Hypertrophy in Borderline Hypertension:  Relationships to Blood Pressure and Sympathetic Drive. Clinical and Experimental Hypertension, 7:243‑256, 1985.

4.     Egan B., Neubig R., Schneider R.H., Julius S. Methods for Measuring Vascular and Nonvascular Alpha-Receptor Sensitivity in Man.  Journal of Cardiovascular Pharmacology, 7(Suppl 6):S153‑S158, 1985.

5.     Julius S., Schneider R.H., Egan B. Suppressed Anger in Hypertension:  Facts and Problems.  In Chesney Mass., Goldstein S., Rosenman, R.  (Eds.) Prevention Research on the Assessment, Correlation and Treatment of Disabling Anger. New York: McGraw Hill, 1985.

6.     Schneider R.H., Julius S., Moss G.E. Physiological Correlates of the Type A Coronary Prone Behavior Pattern and the Influence of Metoprolol ‑ a Preliminary Report, in Proceedings of the IX European Congress of Cardiology, Huber Publications, 1985.

7.     Schneider R.H., Egan B., Johnson E., Drobny H., Julius S. Anger and Anxiety in Borderline Hypertension. Psychosomatic Medicine, 48: 242‑248, l986.

8.     Schneider R.H., Cavanaugh W., Boncheff S. Cost Reductions Through Better Health:  Transcendental Meditation Program Cuts Costs in Half. Business and Health, 4(1):39‑42, 1986.

9.     Schneider R.H., Julius S., Moss G.E., Zweifler A.J., Karunas R. New Markers for Type A Behavior:  Pupil Size and Platelet Epinephrine. Psychosomatic Medicine, 49:579‑590, 1987.

10.  Schneider R.H., Cavanaugh W., Boncheff S. Cost Reductions Through Better Health, in Work and Health Strategies for Maintaining a Vital Work Force, Panel Publications, 1989.

11.  Schneider R.H., Karunas R., Julius S. Ambulatory Blood Pressure Monitoring and Laboratory Reactivity in Type A Behavior and Components.  Psychosomatic Medicine, 51:290‑305, 1989.

12.  Mills P.J., Schneider R.H., Dimsdale J.  Anger Assessment and Reactivity to Stress. Journal of Psychosomatic Research, 33 (3): 379‑382, 1989.

13.  Mills P.M., Schneider R.H., Hill D., Walton K., Wallace R.K. Beta Adrenergic Receptor Sensitivity in Transcendental Meditation Practitioners and Controls. Journal of Psychosomatic Research, 34 (1):29‑33, 1990.

14.  Schneider R.H., Cavanaugh K., Rothenberg S., Averbach R., Robinson D., Wallace R.K. Health Promotion With a Traditional System of Natural Medicine:  Maharishi Ayur‑Veda.  Journal of Social Behavior and Personality, 5 (3):1‑27, 1990.

15.  Schneider R.H., Alexander C.N., Wallace R.K. In Search of an Optimal Behavioral Treatment for Hypertension: A Review and Focus on Transcendental Meditation, in Johnson E.H., Gentry W.D., Julius S. (Eds.), Personality, Elevated Blood Pressure, and Essential Hypertension. Washington: Hemisphere Publishing Corporation, 291‑318, 1992.

16.  Alexander C.N., Robinson P., Orme‑Johnson D., Schneider R.H., Walton K. Effects of Transcendental Meditation Compared to Other Methods of Relaxation and Meditation in Reducing Risk Factors, Morbidity, and Mortality. Homeostasis, 35 (4‑5): 243‑264, 1994.

17.  Schneider R.H. Adrenergic Mechanisms in Type A Behavior., in Cameron, O.G. (Ed.), Adrenergic Dysfunction in Psychobiology. Washington, D.C., American Psychiatric Press; Ch. 11, pp. 275‑297, 1994.

18.  MacLean C., Walton K.G., Wenneberg S., Levitsky D., Mandarino J., Waziri R., Schneider R.H. Altered Responses of Cortisol, GH, TSH and Testosterone to Acute Stress after Four MonthsÕ Practice of Transcendental Meditation (TM).  Annals of the New York Academy of Sciences, 746:381‑384, 1994.

19.  Schneider R.H., Staggers F., Alexander C.N., Sheppard W., Rainforth M., Kondwani K., Smith S., King C. A Randomized Controlled Trial of Stress Reduction for Hypertension in Older African Americans.  Hypertension, 26:820‑827, 1995.

20.  Herron R.E., Schneider R.H., Mandarino J.V., Alexander C.N., Walton K.G.  Cost‑Effective Hypertension Management: Comparison of Drug Therapies With an Alternative Program. Journal of Managed Care, 2(4):427‑437, 1996.

21.  Zamarra J.W., Schneider R.H., Besseghini I., Robinson D., Salerno J. Usefulness of the Transcendental Meditation Program in the Treatment of Patients with Coronary Artery Disease. American Journal of Cardiology, 77:867‑870, 1996.

22.  Alexander C.N., Schneider R.H., Claybourne M., Sheppard W., Staggers F., Rainforth M., Salerno J., Kondwani K., Smith S., Walton K.G., Egan B.  A Trial of Stress Reduction for Hypertension in Older African Americans II. Sex and Risk Subgroup Analysis.  Hypertension, 28(2): 228‑237, 1996.

23.  Wenneberg S.R., Schneider R.H., Walton K.G., MacLean C., Levitsky D., Mandarino J., Waziri R., Wallace R.K. Anger Expression Correlates with Platelet Aggregation. Behavioral Medicine, 22:174‑177, 1997.

24.  Wenneberg S.R., Schneider R.H., Walton K.G., MacLean C., Levitsky D., Mandarino J., Rainforth M., Salerno J., Waziri R., Wallace R.K. A Controlled Study of the Effects of the Transcendental Meditation Program on Ambulatory Blood Pressure and Cardiovascular Reactivity.  International Journal of Neuroscience, 89:15‑28, 1997.

25.  Barnes V., Schneider R.H., Alexander C. Stress, Stress Reduction and Hypertension in African Americans:  An Updated Review. Journal of the National Medical Association, 89(7):464‑476, 1997.

26.  MacLean C., Walton K., Wenneberg S., Levitsky D., Mandarino J., Waziri R., Hillis S., Schneider R.H.  Effects of the Transcendental Meditation Program Adaptive Mechanisms:  Altered Endocrine Responses to Stress After Four Months of Practice. Psychoneuroendocrinology, 22(4):277‑295, 1997.     

27.  Schneider R.H., Charles B., Sands D., Grace D., Averbach R., Rothenberg S. The Significance of the Maharishi Vedic Approach to Health for Modern Health Care and Medical Education.  Modern Science and Vedic Science, 7(1):299‑315, 1997.

28.  Schneider R.H., Nidich S., Salerno J., Sharma H., Robinson C., Nidich R., Alexander C. Lower Lipid Peroxide Levels in Practitioners of the Transcendental Meditation Program. Psychosomatic Medicine, 60:38‑41, 1998.

29.  Calderon R., Schneider R.H., Alexander C., Meyers H. Stress, Stress Reduction and Hypercholesterolemia in African Americans. Ethnicity and Disease, 9:451-462, 1999.

30.  Castillo‑Richmond A., Schneider R.H., Alexander C., Cook R., Meyers H., Haney C., Rainforth M., Salerno J.  Effects of Stress Reduction and Carotid Atherosclerosis in Hypertensive African Americans. Stroke, 31:568-573, 2000.

31.  Nader T., Rothenberg S., Averbach R., Charles B., Fields J., Schneider R.H.  Improvements in Chronic Diseases With a Comprehensive Natural Medicine Approach:  A Review and Case Series.  Behavioral Medicine, 26(I):34-46, 2000.

32.  Nader T., Smith D., Dillbeck M., Schanbacher V., Dillbeck S., Gallois P., Beall-Rougerie S., Schneider R.H., Nidich S., Kaplan G., Belok S.  A Double Blind Randomized Controlled Trial of Maharishi Vedic Vibration Technology in Subjects With Arthritis. Frontiers in Bioscience, 6:h7-h17, 2001.

33.  Nidich S., Schneider R.H., Nidich R., Rainforth M., Scharf D., Salerno J., Smith D., Dillbeck M., Nader T.  Effect of Maharishi Vedic Vibration Technology on Chronic Disorders and Associated Quality of Life.  Frontiers in Bioscience, 6:h1-h6, 2001.

34.  Schneider R.H., Castillo‑Richmond A., Alexander C., Meyers H., Kaushik V., Aranguri C., Norris K., Haney C., Rainforth M., Calderon R., Nidich S.  Behavioral Treatment of Hypertensive Heart Disease in African Americans: Rationale and Design of a  Randomized Controlled Trial. Behavioral Medicine, 27:83-95, 2001.

35.  Schneider R.H., Alexander C., Salerno J., Robinson D., Fields J., Nidich S. Disease Prevention and Health Promotion in the Aging with a Traditional System of Natural Medicine: Maharishi Vedic Medicine (MVM). Journal of Aging and Health, 14(1):57-78, 2002.

36.  Fields J., Walton K., Schneider R.H., Nidich S., Pomerantz R., Suchdev P., Castillo-Richmond A., Payne K., Clark E., Rainforth M.  Effect of a Multimodality Natural Medicine Program on Carotid Atherosclerosis in Older Subjects: A Pilot Trial of Maharishi Vedic Medicine.  American Journal of Cardiology, 89:952-958, 2002.

37.  Bairey Merz C., Dwyer J., Nordstrom C., Walton K., Salerno J., Schneider R.H.  Psychosocial Stress and Cardiovascular Disease, Part I: Pathophysiological Links. Behavioral Medicine, 27:141-146, 2002.

38.  Walton K., Schneider R.H., Nidich S., Salerno J., Nordstrom C., Bairey Merz C.  Psychosocial Stress and Cardiovascular Disease 2: Effectiveness of the Transcendental Meditation Program in Treatment and Prevention.  Behavioral Medicine, 28:106-123, 2002.

39.  Schneider R.H., Salerno J., Nidich S. Future Trends in Use — Focus in a Traditional System of Natural Medicine.  In Cherniak N., Cherniak P. (Eds.)  Alternative Medicine and the Elderly, New York:  Springer-Verlag, 73-87, 2003.

40.  Nidich R., Nidich S., Schneider R.H. The Transcendental Meditation Program and Quality of Life in Breast Cancer Patients: A Feasibility Study.  Journal of Psychosomatic Research, 55:153, 2003.

41.  Nidich S., Schneider R.H., Fields J., Rainforth M. Effects of the Transcendental Meditation Program on Emotional Well-being in Elderly Breast Cancer Patients: Preliminary Results from a Randomized Controlled Study.  Journal of Psychosomatic Research, 55:153-154, 2003.

42.  Nidich S., Grandinetti A., Schneider R.H., Chang H., Ricketts L., Toomey M.  The Transcendental Meditation Program and Cardiovascular Disease in Native Hawaiians. Journal of Psychosomatic Research, 55:144-145, 2003.

43.  Walton K., Fields J., Levitsky D., Harris D., Pugh N., Schneider R.H. Lowering Cortisol and CVD Risk in Postmenopausal Women: A Pilot Study Using the Transcendental Meditation Program.  Annals of the New York Academy of Sciences, 1032:211-5, 2004.

44.  Walton K., Schneider R. H., Nidich S. Review of Controlled Clinical Research on the Transcendental Meditation Program and Cardiovascular Disease: Risk Factors, Morbidity, and Mortality. Cardiology in Review, 12(5):262-266, 2004.

45.  Barnes V., Schneider R.H., Alexander C., Rainforth M., Salerno J., Kondwani K., Staggers F. Impact of the Transcendental Meditation Program on Mortality in Older African Americans with Hypertension — Eight-year Follow Up.  Journal of Social Behavior and Personality, 17:201-216, 2005.

46.  Schneider R.H., Alexander C., Salerno J., Rainforth M., Nidich S. Stress Reduction in the Prevention and Treatment of Cardiovascular Disease in High Risk Underserved Populations: A Review of Controlled Research on the Transcendental Meditation Program.  Journal of Social Behavior and Personality, 17:159-180, 2005.

47.  Kondwani K., Schneider R.H., Alexander C., Sledge C., Staggers F., Clayborne B., Sheppard W., Rainforth M., Krouse L., Orme-Johnson D.  Left Ventricular Mass Regression with the Transcendental Meditation Technique and a Health Education Program in Hypertensive African Americans. Journal of Social Behavior and Personality, 17:181-200, 2005.

48.  Nidich S., Nidich R., Sands D., Schneider R.H., Sharma H., Barnes V., Jossang S., Smith D. Maharishi Rejuvenation Program and Speed of Processing Ability. Journal of Social Behavior and Personality, 17:565-570, 2005.

49.  Nidich S., Schneider R.H., Nidich R., Foster G., Sharma H., Salerno J., Goodman R., Alexander C. Effect of the Transcendental Meditation Program on Intellectual Development in Community-dwelling Older Adults.  Journal of Social Behavior and Personality, 17:217-226, 2005.

50.  Schneider R.H., Alexander C., Staggers F., Orme-Johnson D., Rainforth M., Salerno J., Sheppard W., Castillo-Richmond A., Barnes V., Nidich S.  A Randomized Controlled Trial of Stress Reduction in African Americans Treated for Hypertension Over One Year.  American Journal of Hypertension, 18:88-98, 2005. 

51.  Schneider R.H., Alexander C., Staggers F., Rainforth M., Salerno J., Hartz A., Arndt S., Barnes V., Nidich S. Long-term Effects of Stress Reduction on Mortality in Persons ³ 55 Years of Age with Systemic Hypertension.  American Journal of Cardiology, 95:1060-1064, 2005. 

52.  Walton K., Schneider R.H., Salerno J., Nidich S. Psychosocial Stress and Cardiovascular Disease 3: Clinical and Policy Implications of Research on the Transcendental Meditation Program.  Behavioral Medicine, 30(4):173-83, 2005.

53.  {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Schneider R.H., Walton K., Salerno J., Nidich S. Cardiovascular Disease Prevention and Health Promotion with the Transcendental Meditation Program and Maharishi Consciousness-Based Health Care.  Ethnicity & Disease 16(3 Suppl 4):S4-15-26, 2006.

54.  Paul-Labrador M., Polk D., Dwyer J., Velasquez I., Nidich S., Rainforth M., Schneider R.H., Bairey Merz C. Effects of Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects with Coronary Heart Disease.  Archives of Internal Medicine, 166:1218-1224, 2006.

55.  {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Orme-Johnson D., Schneider R.H., Son Y., Nidich S., Cho Z. Neuroimaging of MeditationÕs Effect on Brain Reactivity to Pain.  NeuroReport, 17(12):1359-63, 2006.

56.  {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Jayadevappa R., Johnson J., Bloom B., Nidich S., Desa S., Chhatre S., Razian D., Schneider R.H. Effectiveness of Transcendental Meditation on Functional Capacity and Quality of Life of African Americans with Congestive Heart Failure: A Randomized Control Study. Ethnicity and Disease, 17:72-77, 2007.   3

57.  Rainforth M., Schneider R.H., Nidich S., King C., Salerno J., Anderson J. Stress Reduction Programs in Patients with Elevated Blood Pressure: A Systematic Review and Meta-analysis. Current Hypertension Reports, 9(6):520-8, 2007.

58.  Travis F., Haaga D., Hagelin J., Tanner M., Nidich S., Gaylord-King C., Grosswald S., Rainforth M., Schneider R.H. Effects of Transcendental Meditation Practice on Brain Functioning and Stress Reactivity in College Students. International Journal of Psychophysiology, 71(2):170-6, 2009. 

59.  Tanner M., Travis F., Gaylord-King C., Haaga D., Grosswald S., Schneider R.H. The Effects of the Transcendental Meditation Program on Mindfulness.  Journal of Clinical Psychology, 65(6):574-89, 2009. 

60.  Nidich S., Fields J., Rainforth M., Pomerantz R., Cella D., Kristeller J., Salerno J., Schneider R.H. A Randomized Controlled Trial of the Effects of Transcendental Meditation on Quality of Life in Older Breast Cancer Patients. Integrative Cancer Therapies, 8(3):228-234, 2009.

61.  Nidich S., Rainforth M., Haaga D., Hagelin J., Salerno J., Travis F., Tanner M., Gaylord- King C., Grosswald S., Schneider R. H. A Randomized Controlled Trial on Effects of the Transcendental Meditation Program on Blood Pressure, Psychological Distress, and Coping in Young Adults. American Journal of Hypertension, 22(12):1326-31, 2009.

62.  Travis F., Haaga A., Hagelin J., Tanner M., Arenander A., Nidich S., Gaylord-King C., Grosswald S., Rainforth M., Schneider R.H. A Self-referential Default Brain State: Patterns of Coherence, Power, and eLORETA Sources During Eyes-closed Rest and Transcendental Meditation Practice. Cognitive Processing, 11:21–30, 2010.

63.  Haaga D., Grosswald S., Gaylord-King C., Rainforth M., Tanner M., Travis F., Nidich S., Schneider R.H. Effects of the Transcendental Meditation Program on Substance Use Among University Students. Cardiology Research and Practice, 2011: 537101, 2011.

64.  {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Orme-Johnson D., Barnes V., Schneider R.H. Effects of the Transcendental Meditation Program on Cardiovascular Risk Factors and Clinical Events, in Heart & Mind: the Practice of Cardiac Psychology, second edition, R. Allan & J. Fisher, Eds. American Psychological Association: Washington, DC, 2012.

65.  Schneider RH, Grimm CE, Rainforth MV, Kotchen T, Nidich SI, {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}C1, Salerno JW, Kotchen JM, Alexander, CN. Stress Reduction in the Secondary Prevention of Cardiovascular Disease: Randomized Controlled Trial of Transcendental Meditation and Health Education in Blacks. Circulation: Cardiovascular Quality and Outcomes, 5:750-758, 2012

66.  {C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}{C}Walton KG, Olshansky B, Crotta E, Schneider RH. A quantitative review of trials of Maharishi Ayurveda for atherosclerotic CVD. Cardiology in Review (in review).

 

 

Abstracts and Presentations – Peer Reviewed

 

1.     Schneider R.H. The Role of the Transcendental Meditation and TM‑Sidhi Program in Medicine:  A Literature Review. Paper presented at the 27th Annual Meeting of the Academy of Psychosomatic Medicine, Bal Harbour, Fla., October, 1980.

2.     Schneider R.H., Smith C.B., Zweifler A.J. Alteration of Platelet Alpha2‑adrenoreceptor Binding and Function by Clonidine in Hypertensive Patients. Clinical Research, 32:247A, 1984.

3.     Schneider R.H., Smith C.B., Zweifler A.J.  Clonidine Treatment Decreases Platelet Alpha2‑adrenoreceptors in Hypertensive Patients. Federation Proceedings, 43(3):839, 1984.

4.     Schneider R.H., Egan B., Johnson E., Drobny H., Julius S. Anger and Anxiety in Borderline Hypertension. Paper presented at the Fifth Annual Meadow Brook Symposium on Hypertension, Rochester, Mich., June 8, 1984.

5.     Schneider R.H., Julius S., Rosenman R.H. A Double‑blind Study: Adrenergic Blockade with Metoprolol in Type A and Type B Subjects, in Innovations for Established Cardiovascular Drugs, IXth European Congress of Cardiology Abstracts, Dusseldorf, West Germany, July 1984.

6.     Schneider R.H., Julius S., Moss G.E. New Markers for Type A Behavior: Platelet Epinephrine and Pupil Size. Paper presented at the American Psychosomatic Society Annual Meeting, Washington, D.C., March 31, 1985 and Psychosomatic Medicine, 47: 89, l985.

7.     Schneider R.H., Cavanaugh K., Kasture H.S., Rothenberg S., Averbach R., Wallace R.K.  Improvements in Health Symptoms with the Maharishi Ayurveda Prevention Program.  Paper presented at the Eighth World Congress of the International College of Psychosomatic Medicine, Chicago, Ill., Sept. 4‑7, 1985.

8.     Schneider R.H., Orme‑Johnson D., Kesterson J., Wallace R.K. Physiological and Psychological Correlates of Ayurvedic Psychosomatic Typing. Paper presented at the Eighth World Congress of the International College of Psychosomatic Medicine, Chicago, Ill., Sept. 4‑7, 1985.

9.     Hill D., Wallace T., Van Boxel J., Schneider R.H., Mills P., Wallace R. Altered Beta Adrenergic Receptor Function in a Monocyte‑like Cell Line. Paper presented at the Society for Neuroscience Annual Meeting, October, l985.

10.  Schneider R.H., Julius, S. Treatment of Type A Behavior with Low Dose Beta adrenergic Blockade: A Double Blinded Trial of Metoprolol vs. Placebo. Paper presented at the Seventh Annual Scientific Session of the Society for Behavioral Medicine, San Francisco, Calif., March 5‑8, 1986.

11.  Schneider R.H., Schramm W., Akil H., Watson S., Julius, S. Neuroendocrine Responsiveness in Type A and B Behavior: Luteinizing Hormone, Testosterone, Cortisol, Beta‑endorphin, Epinephrine, and Norepinephrine. Paper presented at the American Psychosomatic Society Annual Meeting, Baltimore, Md., March 20, 1986 and published in Psychosomatic Medicine, 48:302‑303, l986.

12.  Orme‑Johnson D., Schneider R.H. Reduced Healthcare Utilization in Transcendental Meditation Practitioners: Maharishi Ayurveda as Preventive Medicine. Paper presented at the Society for Behavioral Medicine Annual Meeting, Washington, D.C., March 1987.

13.  Schneider R.H., Mills P.J., Schramm W., Wallace R.K. Luteinizing Hormone: A Marker for Type A Behavior and its Modification by the Transcendental Meditation Program?  Paper presented at the American Psychosomatic Society Annual Meeting. Philadelphia, Penn., March 26‑28, 1987, and Psychosomatic Medicine, 49(2):212‑213, l987.

14.  Mills P.J., Schneider R.H., Hill D., Walton K., Wallace R.K.  Lymphocyte Beta‑adrenergic Receptors and Cardiovascular Responsivity in TM Participants and Type A Behavior.  Paper presented at the American Psychosomatic Society Annual Meeting. Philadelphia, Penn., March 26‑28, 1987, and Psychosomatic Medicine, 49(2):211, 1987.

15.  Schneider R.H., Mills P.J., Schramm W., Wallace R.K., Walton K.G. Differential Endocrine Responses to Stress in Meditating and Non‑meditating Type A Subjects: A Reflection of Differences in Central Serotonergic Tone?  Paper presented at the XVIII International Congress of the International Society of Psychoneuroendocrinology, Chapel Hill, N.C., June 1987, and Neuroendocrinology Letters, 9:181, 1987.

16.  Mills P.J., Schneider R.H. Anger Expression and Reactivity. Paper presented at the Annual Meeting of the American Psychosomatic Society, Boston, Mass., April 1988.

17.  Schneider R.H., Mills P.J., Schramm W., Walton K.G., Dillbeck M.C., Wallace K. Dehydroepiandrosterone Sulfate (DHEAS) Levels in Transcendental Meditation Practitioners.  Psychosomatic  Medicine, 51(2): 256, 1989.

18.  Smith D.E., Glaser J.L., Schneider R.H., Dillbeck M.C. Erythrocyte Sedimentation Rate (ESR) and the Transcendental Meditation (TM) Program. Psychosomatic Medicine, 51(2):259, 1989.

19.  Fields J.Z., Rawal P.A., Hagen J., Ing T., Wallace R.K., Tomlinson P.F., Schneider R.H.  Oxygen Free Radical (OFR) Scavenging Effects of an Anti‑carcinogenic Natural Product, Maharishi Amrit Kalash (MAK). The Pharmacologist, 32(3):155, Abstract 74:208, 1990.

20.  Fields J.Z., Schneider R.H., Wichlinski L., Hagen J. Anti‑aging Effects of a Natural Product, Maharishi Amrit Kalash. Conference on Antioxidants and Degenerative Diseases.  Berkeley, Calif., Jan. 26‑27, 1990.  Satellite Meeting of the International Society for Free Radical Research.

21.  Fields J.Z., Eftekhari E., Hagen J., Wichlinski L.J., Schneider R.H. Anti‑aging and Oxygen Free Radical (OFR) Scavenging Effects of an Anti‑carcinogenic Natural Product, Maharishi Amrit Kalash (MAK). Journal of the Federation of American Societies for Experimental Biology, 5(5): Abstract 7926, 1991.

22.  MacLean C., Walton K.G., Wenneberg S.R., Levitsky D.K., Mandarino J.V., Waziri R., Schneider R.H. Reduced TSH Reactivity During Acute Stress After Four MonthsÕ Practice of Transcendental Meditation.  Paper presented at the 50th Annual Meeting of the American Psychosomatic Society, New York, April 2, 1992.

23.  Schneider R.H., Alexander C.N., Staggers F., Sheppard W., Gaylord C., Gelderloos P., Smith S., Kondwani K., Rainforth M., Cooper R. Stress Management in Elderly Blacks with Hypertension. Proceedings of the Second International Conference on Ethnicity and Disease, Salvador, Bahia, Brazil, August, 1991.

24.  MacLean C., Schneider R.H., Wenneberg S.R., Levitsky, D.K., Waziri R., Walton K.G. Reactivity of Plasma Serotonin to Psychological Stress. Paper presented at the 23rd Annual Meeting for the American Society for Neurochemistry, Houston, Texas, March 18, 1992.

25.  Wenneberg S.R., Schneider R.H., MacLean C., Levitsky D.K., Walton K.G., Mandarino J.V., Wallace R.K., Waziri R. Anger / Hostility Correlates with Platelet Aggregation During Mental Stress. Presented at the 50th Annual Meeting of the American Psychosomatic Society, New York, April 2, 1992.

26.  MacLean C., Walton K.G., Wenneberg S.R., Levitsky D.K., Mandarino J.V., Waziri R., Schneider R.H. Altered Cortisol Response to Stress After Four MonthsÕ Practice of the Transcendental Mediation Program. Society for Neuroscience Abstracts, 1992.

27.  Alexander C.N., Schneider R.H. Effects of Transcendental Meditation Compared to Relaxation in Promoting Health and Reducing Mortality in the Elderly. Presented at the Joint Meeting of the Collegium Internationale Activitatis Nervosae Superioris and the International Society of Behavioral Medicine, Hanover Medical School, Hanover, Germany, July 14, 1992.

28.  MacLean C., Walton K.G., Wenneberg S.R., Levitsky D.K., Mandarino J.V., Waziri R., Schneider R.H. Apparent Dehydroepiandrosterone Response to Acute Laboratory Stress. Society for Neuroscience Abstracts, 1993.

29.  MacLean C., Walton K.G., Wenneberg S.R., Levitsky D.K., Mandarino J.V., Waziri, R., Schneider R.H.  Altered Response of Cortisol, GH, TSH, and Testosterone to Acute Stress After Four MonthsÕ Practice of Transcendental Meditation (TM). Presented at the New York Academy of Sciences Meeting on Brain Corticosteroid Receptors: Studies on Mechanism, Function and Neurotoxicity of Corticosteroid Action, Virginia, March 2‑5, 1994.

30.  Wenneberg S.R., Schneider R.H., MacLean C., Levitsky D.K., Walton K.G., Mandarino J.V., Wallace R.K., Waziri R. The Effects of Transcendental Meditation on Ambulatory Blood Pressure and Cardiovascular Reactivity. Psychosomatic Medicine, 56(2): p. 168 (Abstract), 1994.

31.  Zamarra J.W., Schneider R.H., Wallace R.K. Stress Reduction in the Treatment of Ischemic Heart Disease: Effects of the Transcendental Meditation Program.  Presented at the Third International Congress of Behavioral Medicine, Amsterdam, The Netherlands, July 6‑9, 1994.

32.  Schneider R.H., Nidich S., Sharma H.M., Robinson C., Foster, G., Nidich R., Goodman, R. Effects of the Transcendental Meditation Program on Serum Lipid Peroxide Levels in Community‑dwelling Elderly Adults. Presented at the Third International Congress of Behavioral Medicine, Amsterdam, The Netherlands, July 6‑9, 1994.

33.  Alexander, C., Schneider, R.H. Prevention and Treatment of Drug Abuse with the Transcendental Meditation Program. Presented at the First International Conference on Lifestyle and Health, New Delhi, India, January 20-21, 1995.

34.  Alexander C.N., Schneider R.H., Clayborne M. Stress Reduction in Hypertensive Elderly African American Women: Comparison of Transcendental Meditation and Progressive Relaxation. Proceedings of the Society of Behavioral MedicineÕs Sixteenth Annual Scientific Sessions. Annals of Behavioral Medicine, 17 (supplement):S086, 1995.

35.  Schneider R.H., Staggers F., Alexander C., Sheppard W., Rainforth M., Kondwani K., Smith S. A Randomized Controlled Trial of Stress Reduction for the Treatment of Hypertension in Older African Americans: Implications for Preventive Medicine and Public Health. Presented at the NIH Office of Alternative Medicine Conference on Complementary and Alternative Medicine Research Methodology, Washington, D.C., April 26‑28, 1995.

36.  Alexander C.N., Schneider R.H., Rainforth M., King C.G., Kondwani K., Staggers F., Sheppard W., Smith S. A Randomized Controlled Trial of Stress Reduction for the Treatment of Hypertension in Older African Americans: Quality of Life Results. Presented at the Tenth International Interdisciplinary Conference on Hypertension in Blacks, St. Thomas, Virgin Islands, June 24‑29, 1995.

37.  Schneider R.H. Review of Research and Clinical Applications of a Sophisticated and Comprehensive System of Traditional Natural Health Care. Congress of the International College of Psychosomatic Medicine, Jerusalem, Israel, Sept. 10-15, 1995.

38.  Levitsky D.K., Walton K.G., MacLean C.R. K., Pugh N.D.C., Wenneberg S., Schneider R.H., Mandarino J.V., Hillis S., Waziri R. Reversal of Neuroendocrine Effects of Chronic Stress by the Transcendental Meditation Technique.  Society for Neuroscience Abstracts 21(3); 1389, 1995.

39.  Alexander C.N., Barnes V.A., Schneider, R.H., Langer E., Newman R., Chandler H., Davis J., Rainforth M. A Randomized Controlled Trial of Stress Reduction on Cardiovascular and All-cause Mortality in the Elderly: Results of eight-year and 15-year Follow-ups. Circulation 93(3): 629,1996.

40.  Schneider R.H. Review of Controlled Trials of Stress Reduction with the Transcendental Meditation Program in the Treatment of Hypertension and Prevention of Cardiovascular Disease.  Presented at the Satellite Symposium of the 16th Scientific Meeting, International Society of Hypertension, Ann Arbor, Mich., June 19, 1996.

41.  Barnes V., Schneider R.H., et al. A Randomized Trial of Stress Reduction in Older African American Hypertensives:  Five Year Follow-up of Cardiovascular and All-cause Mortality. Presented at the 11th Interdisciplinary Conference of the International Society on Hypertension in Blacks, New Orleans, La., July 14-17, 1996.

42.  Schneider R.H., Alexander C.N., Salerno J.W.  Prevention of Cardiovascular Disease with Transcendental Meditation: Effects on Risk Factors. Presented at the 10th  European Health Psychology Society Conference, Dublin, Ireland, Sept. 4-6, 1996.

43.  Alexander C.N., Schneider R.H., Barnes V.A., Rainforth M., Newman R.I., Davies J.L., Chandler H.M., Robinson P.M. Effects of Transcendental Meditation on Psychological Risk Factors, Cardiovascular and All-cause Mortality: A Review of Meta-analyses and Controlled Clinical Trials. Presented at the 10th European Health Psychology Society Conference, Dublin, Ireland, Sept. 4-6, 1996.

44.  Alexander C.N., Schneider R.H., Staggers F., Rainforth M., Sheppard W., Clayborne M., Kondwani K., Smith S., Murray P. Effects of Stress Reduction on Improved Quality of Life in Hypertensive African Americans: A Randomized Controlled Trial of Transcendental Meditation and Progressive Relaxation.  Presented at the 12th  International Interdisciplinary Conference on Hypertension in Blacks, London, England, July 20-24, 1997.

45.  Clayborne M., Alexander C.N., Schneider R.H., Staggers F., Rainforth M., Sheppard W., Kondwani K., Smith, S.  Effects of Stress Reduction on Anger and Cardiovascular Reactivity in Hypertensive African Americans: A Randomized Controlled Trial of Transcendental Meditation and Progressive Relaxation. Presented at the 12th  International Interdisciplinary Conference on Hypertension in Blacks, London, England, July, 20-24, 1997.

46.  Akanno J., Haney C., Kaushik V., Alexander C., Schneider R.H., Norris K. Baseline Characteristics of Patients in the ÔStress Reduction and Education in the Control of Hypertension Study.Õ  Presented at the 12th  International Interdisciplinary Conference on Hypertension in Blacks, London, England, July 20-24, 1997.

47.  Alexander C.N., Schneider R.H., Travis F. Higher States of Consciousness and Health: Review of Neurophysiological Correlates and Clinical Efficacy of the Maharishi Vedic Approach to Health. Presented at the Annual Meeting of the Israel Psychological Association, Tel Aviv University, Tel Aviv, Israel, Oct. 27, 1997.

48.  Herron R., Schneider R.H., Alexander C.N., Sheppard W., Staggers F. Effects of Behavioral Intervention for Hypertension on Medicaid Utilization. Presented at the 70th Scientific Sessions American Heart Association National Heart, Lung, Blood Institute Cardiovascular Minority Researcher Supplement Awardee Session, Lake Buena Vista, Fla., Nov. 9, 1997.

49.  Schneider R.H. Stress, Stress Reduction and Hypertension in African Americans in Non‑traditional Therapies. Presented at the 13th International Interdisciplinary Conference on Hypertension in Blacks, Charleston, S.C., July 12‑15, 1998.

50.  Castillo‑Richmond A., Schneider R.S., Alexander C.N., Cook R., Meyers H., Rainforth M. Effects of the Transcendental Meditation Program on Carotid Atherosclerosis.  Presented at the 13th International Interdisciplinary Conference on Hypertension in Blacks, Charleston, S.C., July 12‑15, 1998.

51.  Calderon R., Schneider R., Alexander C. Stress, Stress reduction and Hypercholesterolemia in African Americans: A review and Preliminary Report. Presented at the 13th International Interdisciplinary Conference on Hypertension in Blacks, Charleston, S. C., July 12-15, 1998.

52.  Schneider R.H., Alexander C.N., Rainforth M., Salerno J., Aguilar M. Randomized Controlled Trials of Effects of Transcendental Meditation Program on Cancer and All‑cause Mortality: A Meta‑analysis.  Annals of Behavioral Medicine, 21(Supplement):S012, 1999.

53.  Schneider R.H., Alexander C.N., Staggers F., Rainforth M., Salerno J., Aguilar‑Cervantes M., Nidich S. Randomized Controlled Trials of Effects of the Transcendental Meditation Program on Cancer, Cardiovascular, and All‑cause Mortality: A Meta‑analysis. Society for Behavioral Medicine Annual Meeting, San Diego, Calif., March 3‑6, 1999.

54.  Schneider R.H. Behavioral Techniques for Stress Reduction: A Review of the Literature.  Presentation to the Expert ConsultantÕs Workgroup on Stress and Preterm Delivery, Atlanta, Ga., Sept. 23‑24, 1999.

55.  Schneider R.H., Nidich, S. The Transcendental Meditation Program and Improved Physical Health and Psychological Well-being: A Review of Research. Cancer Symposium 2000, Hope Center, Terre Haute, Ind., December, 1999.

56.  Nidich S., Schneider R.H.  An Analysis of Meditation Research in the Context of the Biobehavioral Model of Psychosocial Stress.  Department of Psychology, Indiana State University, Terre Haute, Ind., December, 1999.

57.  Schneider R.H. at Cedars Sinai Cardiology Grand Round. The Effects of the Transcendental Meditation Program on Stress-related Diseases: Review of Controlled Clinical Studies, Cedars Sinai Medical Center, Los Angeles, Calif., Feb. 23, 2000.

58.  Schneider R.H., Nidich S. Meditation, Stress and CVD Risk Factors: A Review of Research.  School of Medicine, Duke University, Durham, N.C., Feb. 25, 2000.

59.  Schneider R.H., Nidich S. Effects of the Transcendental Meditation Program on CVD Risk Factors: Traditional and Psychosocial. School of Public Health, University of North Carolina, Chapel Hill, N.C., Feb. 25, 2000.

60.  Schneider R.H., Nidich S. A Review of Research on Substance Abuse with the Transcendental Meditation Program, Center for Addictions, School of Medicine, University of Minnesota, Minneapolis, Minn., June 21-22, 2000.

61.  Castillo-Richmond A., Schneider R.H., Alexander C., Cook R., Myers H., Nidich S., Haney C., Rainforth M., Salerno J. Effects of the Transcendental Meditation Program on Carotid Atherosclerosis in Hypertensive African American Women, presented to the International Society for Hypertension in Blacks, Las Croabas, Puerto Rico, July, 2000.

62.  Schneider R.H. A Review of Research on the Effects of Transcendental Meditation on Substance Abuse. Presented at the Annual Meeting of the American Public Health Association, Boston, Mass., Nov. 12-15, 2000.

63.  Nidich S., Schneider R.H., Rainforth M., Grim C. Effects of the Transcendental Meditation Program on Depression in African Americans with Coronary Artery Disease.  Presented to the Annual Conference of the Society of Behavioral Medicine, Seattle, Wash., March 21-24, 2001.

64.  Nidich S., Schneider R.H.  Effect of the Transcendental Meditation Program on the Quality of Life of Cancer Patients. Presented to the Annual Conference of the Society of Behavioral Medicine, Seattle, Wash., March 21-24, 2001. 

65.  Schneider R.H. Stress Reduction in the Prevention and Treatment of Cardiovascular Disease: A Review of Controlled Clinical Studies on Transcendental Meditation and Maharishi Vedic Medicine.  Presented at Preventive Medicine 2001: Annual Meeting of the American College of Preventive Medicine, Miami, Fla., Feb. 22-25, 2001.

66.  Schneider R.H. Chairperson, Applications of Complementary and Alternative Medicine (CAM) to Clinical Preventive Service Delivery, American College of Preventive Medicine, Miami, Fla., Feb. 22-25, 2001.

67.  Nidich S., Schneider R.H., Rainforth M., Grim C. Effects of the Transcendental Meditation Program on Depression in African Americans with Coronary Artery Disease. Presented to the Annual Conference of the Society of Behavioral Medicine, Seattle, Wash., March 21-24, 2001.

68.  Schneider R.H., Nidich S, Salerno J. The Transcendental Meditation Program:  Reducing the Risk of Heart Disease and Mortality and Improving Quality of Life in African Americans. Selected Proceedings from Research Center in Minority Institutions (RCMI) Scientific Conference: Ethnicity and Aging in the 21st Century.  Ethnicity & Disease, 11(1):159-160, 2001.

69.  Walton K.G., Schneider R.H. Prevention and Treatment of Cardiovascular Disease with Transcendental Meditation and Maharishi Vedic Medicine — Results of Controlled Clinical Research.  Presentation at the Seventh Medical Research Conference of the Trinidad & Tobago Medical Association, Port of Spain, Trinidad, Nov., 18, 2001.

70.  Schneider R.H.  The Prevention and Treatment of Cardiovascular Disease with Maharishi Vedic Medicine: A Review of Controlled Clinical Research. University of Michigan Medical School, Ann Arbor, Mich., Feb. 4, 2002.

71.  Paul-Labrador M., Bairey Merz C.N., Schneider R.H., Nidich S., Dwyer J.  The Effects of Transcendental Meditation on Risk Factors for Cardiovascular Disease. Presented at the International Scientific Conference on Complementary, Alternative and Integrative Medical Research, Boston, Mass., April 12-14, 2002.

72.  Nidich S., Castillo-Richmond A., Schneider R.H., Cook R., Rainforth M., Myers H.  Transcendental Meditation and Regression of Carotid Atherosclerosis in African Americans: Subgroup Risk Factor Analysis. Presented at the International Scientific Conference on Complementary, Alternative and Integrative Medical Research, Boston, Mass., April 12-14, 2002.

73.  Schneider R.H., Alexander C., Staggers F., Rainforth M., Salerno J., Aguilar-Cervantes M., Nidich S., Hartz A., Arndt S. Effects of Meditation on Mortality in Older Persons: Nine-year Follow-up of Two Randomized Controlled Trials. Presented at the International Scientific Conference on Complementary, Alternative and Integrative Medical Research, Boston, Mass., April 12-14, 2002.

74.  Schneider R.H. Herbal Preparations: Implications for Prevention and Treatment of Chronic Disorders and Aging. Presented at The Complementary and Alternative Research Center, UCLA School of Medicine, Los Angeles, Calif., April 30, 2002.

75.  Schneider R.H. The Prevention and Treatment of Cardiovascular Disease in a Traditional System of Natural Medicine: Controlled Clinical Research on Maharishi Vedic Medicine, Baltimore, Md., May 14, 2002.

76.  Walton K., Schneider R.H., Strayhorn G., Lollis C., Randall O., Xu S., Kondwani K., Oboho K., Ofili E., Nidich S., King C., Rainforth M. Effect of Maharishi Vedic Medicine on Cardiovascular Disease and Related Stress Factors in Older African American Women: Rationale and Design of a Clinical Trial.  Paper presented at the 17th Annual International Interdisciplinary Conference on Hypertension and Related Risk Factors in Ethnic Populations (ISHIB2002), Miami, Fla., June 8-12, 2002.

77.  Schneider R.H. The Prevention and Treatment of Cardiovascular Disease with Maharishi Vedic Medicine: A review of Controlled Clinical Research. Presented at the 46th Annual Research Conference of the American Osteopathic Association, Las Vegas, Nev., Oct. 7-10, 2002.

78.  Nidich S., Grandinetti A., Schneider R.H., Healani K., Ricketts L., Toomey M. Stress, Stress Reduction and CVD in Native Hawaiians: Rationale, Design, and Feasibility Data for a Trial of the Transcendental Meditation Program and Health Education. World Congress on Psychosomatic Medicine, Hawaii, August, 2003.

79.  Walton K.G., Fields J.Z., Levitsky D.K., Harris D.A., Pugh N.D., Schneider R.H.  Lowering Cortisol and CVD Risk in Postmenopausal Women: A Pilot Study Using the Transcendental Meditation Program. Oral presentation at the 34th Annual International Society for Psychoneuroendocrinology Conference, Rockefeller University, New York, Sept. 7-9, 2003.

80.  Schneider R.H., Alexander C., Staggers F., Orme-Johnson D., Rainforth M., Salerno J., Castillo-Richmond A., Barnes V., Nidich S. Effects of Stress Reduction on Hypertension in African Americans: A Randomized Controlled Trial Over One Year. Presented at the American Heart Association Scientific Sessions, Orlando, Florida, November 9-12, 2003.

81.  Paul-Labrador M., Bairey Merz C., Dwyer J., Polk D., Chen Y., Perfetti R., Nidich S., Rainforth M., Schneider R.H. Transcendental Meditation Improves Insulin Resistance in Coronary Artery Disease Subjects: A Randomized Controlled Trial. Circ 108(17);IV-781, 2003

82.  Salerno J., Schneider R.H., Alexander C., Orme-Johnson D., Castillo-Richmond A., Rainforth M., Nidich S. A Controlled Trial of Effects of Stress Reduction on Left Ventricular Mass in Hypertensive African Americans. Presented at the International Society for Hypertension in Blacks, Detroit, Mich, July 2004 (abstract published in the official journal of ISHIB, Ethnicity and Disease, vol 14, Autumn, S2-54),  2004.

83.  Grim C., Dalmar A., Fenderson H., LaFave A., Faizuddin M., Lawrence M., Nidich S., Schneider R.H. Stress Reduction and Prevention of Cardiovascular Morbidity and Mortality in African Americans with Angiographic CAD. Presented at the International Society for Hypertension in Blacks, Detroit, Mich, July 2004.  Abstract published in Ethnicity and Disease 14(Autumn): S2-57, 2004.

84.  Newberg A., Travis F., Wintering N., Nidich S., Schneider R.H. Cerebral Glucose Metabolic Changes Associated with a Meditation Based Relaxation Technique. Journal of Nuclear Medicine 47: 314P, 2006.

85.  Schneider R.H., Olshansky B.  Symposium – Integrative Cardiology: Evidence Based Applications of Traditional Systems of Natural Medicine and the Heart-Mind Connection, co-chair at American College of Cardiology. Atlanta, Ga., March 2006.

86.  Schneider, R.H. Review of Clinical Trials of the Transcendental Mediation Program in Cardiovascular Disease Prevention. Presentation at Symposium – Integrative Cardiology: Evidence Based Applications of Traditional Systems of Natural Medicine and the Heart-Mind Connection, American College of Cardiology, Atlanta, Ga., March 2006.

87.  Olshansky B., Chung M., Dusek J., Schneider R.H., Leopold D., Costello R.  Complementary and Alternative Medicine in Cardiology Practice: Are We Integrating? Presented at North American Research Conference on Complementary & Integrative Medicine, Edmonton, Canada, May 2006.

88.  Walton K., Randall O., Nidich S., Gaylord-King C., Harris C., Strayhorn G., Rainforth M., Cavanaugh K., Salerno J., Xu S., Schneider R.H. Behavioral Treatment of Metabolic Syndrome in Older African American Women Part 1: Baseline Comparisons and a Composite Syndrome Index. (Abstract # 33). Paper presented at ISHIB 2006: 21 Annual International Interdisciplinary Conference on Hypertension and Related Cardiovascular Risk Factors in Ethnic Populations, June 2006; Atlanta, Ga.

89.  Walton K., Randall O., Nidich S., Gaylord-King C., Harris C., Strayhorn G., Rainforth M., Cavanaugh K., Salerno J., Xu S., Schneider R.H. Behavioral Treatment of Metabolic Syndrome in Older African American Women Part 2: Baseline Comparisons and a Composite Syndrome Index. (Abstract # 34). Paper presented at ISHIB 2006: 21 Annual International Interdisciplinary Conference on Hypertension and Related Cardiovascular Risk Factors in Ethnic Populations, Atlanta, Ga. June 2006

90.  Schneider, R.H. Meditation and Cardiovascular Disease: Review of Controlled Clinical Research and Total Heart Health: How to Prevent and Reverse Heart Disease with Maharishi Vedic Approach to Health. Presented at John Hopkins University School of Medicine, Baltimore, Md., June, 2006.

91.  Schneider, R.H. Clinical Trials in Behavioral Medicine. Presented at Academy of Behavioral Medicine Research. Amelia Island, Fla., June 2006.

92.  Schneider, R.H., Alexander, C., Orme-Johnson, D., Castillo-Richmond, A., Rainforth, M., Nidich, S., Salerno, J. Lifestyle Modification in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Stress Reduction and Health Education in Hypertensive African Americans. Presented at the 21st Meeting of the International Society of Hypertension. Fukuoka, Japan, Oct. 2006.

93.  Schneider R.H., Nidich S., Kotchen J., Kotchen T., Grim C., Rainforth M., Gaylord-King C., Salerno J.  Effects of Stress Reduction on Clinical Events in African Americans with Coronary Heart Disease: A Randomized Controlled Trial.  Presented at the American Heart Association Scientific Sessions. Orlando, Fla., Nov. 14-18, 2009. Circulation.120:S461, 2009.

94.  Gaylord-King C., Walton K., Rainforth M., Randall O., Salerno J., Nidich S., Harris C., Xu .S, Strayhorn G., Schneider R.H. Effects of Stress Reduction on Dyslipedemia in Diabetic African American Women. Presented at the Annual Meeting of the American Public Health Association. Philadelphia, Penn., Nov.7-11, 2009. 

95.  Salerno J., Schneider R.H., Rainforth M., Myers H., Gaylord- King C. Stress Reduction and Atherosclerotic CVD in African Americans. Presented at the 31st Annual Meeting of the American Psychosomatic Society, Portland, Ore., March 10 – 13, 2010. Journal of Psychosomatic Medicine 72(3): A-149, 2010.

96.  Nidich S., Toomey M., Myers H., Rainforth M., Grandinetti A., Salerno J., Gaylord-King C., Schneider R.H. Reduced Symptoms of Depression in Older Minority Subjects At Risk for CVD: Randomized Controlled Mind-body Intervention Trials. Presented at the 31st Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine. Seattle, Wash., April 7 – 10, 2010.


 

 

What will he talk about?
Dr Schneider will present his research findings and explain why the American Heart Association recommends Transcendental Meditation in the treatment of high blood pressure.

Why is this important?
Cardiovascular disease remains the leading cause of death in New Zealand. Many of these deaths are premature and preventable. Robert Schneider has assumed the burden of proof by conducting randomised controlled trials into an effective alternative to pharmaceutical interventions. Transcendental Meditation may be even more effective than statins. Statins typically reduce cardiac events by 30-40%.

CME endorsed 
Dr Schneider's talks to doctors in Auckland, Wellington and Christchurch have been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and are approved for up to 1.25 credits CME for General Practice Educational Programme Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes.

Dr Schneider's tour has been arranged by Maharishi Foundation (Inc.) in association with the University of Auckland Faculty of Medical and Health Sciences, and the Departments of General Practice of the University of Otago Wellington and Christchurch, with sponsorship from EBOS Healthcare and Fuji Xerox


EBOS GROUP Limited
 

Public Seminar

Auckland Event

Sunday 6 October 2013

Public seminar on Total Heart Health, how to heal your emotional and physical heart

Novotel Ellerslie, Rimu Room 1
72/112 Green Lane E, Greenlane
1:30pm-4:30pm
(Afternoon Tea included)

event details

Novotel Ellerslie, Rimu Room 1
72/112 Green Lane E, Greenlane
1:30pm-4:30pm

$55 per person - Afternoon Tea included

Health Professionals' Meeting

Auckland Event

Monday 7 October 2013

Why TM is good for your heart

Novotel Ellerslie, Rimu Room 1
72/112 Green Lane E, Greenlane
7pm-8:30pm

Endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 1.25 credits CME for General Practice Educational Programme Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes.

On Campus Event

Auckland Event

Monday 7 October 2013

Why TM is good for your heart

Auckland University School of Population Health
Bldg 732, Lecture Theatre 201
261 Morrin Rd, Glen Innes
12:30pm-1:30pm

Public Talk

Wellington Event

Tuesday 8 October 2013

Why TM is good for your heart

Amora Hotel Boardroom 1
170 Wakefield St, Te Aro
5:45pm-7pm

event details

Amora Hotel Boardroom 1
170 Wakefield St, Te Aro
5:45pm-7pm

$15 per person

Health Professionals' Meeting

Wellington Event

Tuesday 8 October 2013

Why TM is good for your heart

Small Lecture Theatre, University of Otago, Wellington Hospital, Mein St. Newtown
7:30pm-9pm

Endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 1.25 credits CME for General Practice Educational Programme Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes.

Public Talk

Christchurch Event

Wednesday 9 October 2013

Why TM is good for your heart

Treasury Room, The George Hotel
50 Park Tce, Christchurch
5:45pm-7:00pm

event details

Treasury Room, The George Hotel
50 Park Tce, Christchurch
5:45pm-7:00pm

$15 per person

Health Professionals' Meeting

Christchurch Event

Wednesday 9 October 2013

Why TM is good for your heart

Beaven Lecture Theatre
7th floor, Medical Centre
Christchurch School of Medicine (via hospital)
7:30pm-9pm

Endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 1.25 credits CME for General Practice Educational Programme Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes.

On Campus Event

Christchurch Event

Wednesday 9 October 2013

Why TM is good for your heart

HP Seminar Room, NZi3
University of Canterbury
12:30pm-1:30pm